臨床外科73巻13号

2018年12月発行

特集 ここがポイント！—サルコペニアの病態と対処法

各論2・周術期管理と手術・治療の留意点

集学的治療とサルコペニア

著者： 吉川貴己¹ 青山徹²

所属機関： ¹国立がん研究センター中央病院胃外科 ²横浜市立大学外科治療学

ページ範囲：P.1490 - P.1494

文献概要

【ポイント】
◆これまでの報告より，様々な癌種においてサルコペニアは，癌の集学的治療の有害事象発現や治療継続性に負の影響を与えることがわかってきた．
◆サルコペニア対策として，特殊な栄養剤の投与や運動療法など，今後の展開も注目される．

参考文献

1）Prado CM, Baracos VE, McCargar LJ, et al：Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 13：3264-3268, 2007

2）Prado CM, Baracos VE, McCargar LJ, et al：Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15：2920-2926, 2009

3）Sakuramoto S, Sasako M, Yamaguchi T, et al：Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357：1810-1820, 2007

4）Aoyama T, Yoshikawa T, Shirai J, et al：Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer. Ann Surg Oncol 20：2000-2006, 2013

5）Yamada T, Hayashi T, Cho H, et al：Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgery. Gastric Cancer 15：34-41, 2012

6）Aoyama T, Kawabe T, Fujikawa H, et al：Loss of LBM as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol 22：2560-2566, 2015

7）Tan BH, Brammer K, Randhawa N, et al：Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Eur J Surg Oncol 41：333-338, 2015

8）Antoun S, Baracos VE, Birdsell L, et al：Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol 21：1594-1598, 2010

9）Huillard O, Mir O, Peyromaure M, et al：Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients. Br J Cancer 108：1034-1041, 2013

10）Dalal S, Hui D, Bidaut L, et al：Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation：a pilot study. J Pain Symptom Manage 44：181-191, 2012

11）Ryan AM, Reynolds JV, Healy L, et al：Enteral nutrition enriched with eicosapentaenoic acid（EPA）preserves LBM following esophageal cancer surgery：results of a double-blinded randomized controlled trial. Ann Surg 249：355-363, 2009

12）Healy LA, Ryan A, Doyle SL, et al：Does Prolonged Enteral Feeding With Supplemental Omega-3 Fatty Acids Impact on Recovery Post-esophagectomy：Results of a Randomized Double-Blind Trial. Ann Surg 266：720-728, 2017

13）Ida S, Hiki N, Cho H, et al：Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer. Br J Surg 104：377-383, 2017

14）Lønbro S, Dalgas U, Primdahl H, et al：Progressive resistance training rebuilds LBM in head and neck cancer patients after radiotherapy--results from the randomized DAHANCA 25B trial. Radiother Oncol 108：314-319, 2013